2022

【英文論文】

1. C Motozono, M Toyoda, TS Tan, H Hamana, Y Goto, Y Aritsu, Y Miyashita, H Oshiumi, K Nakamura, S Okada, K Udaka, M Kitamatsu, H Kishi, T Ueno: The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T cell recognition. Nat Comm 13:5440 (2022) doi:10.1038/s41467-022-33068-4

2. TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, C Motozono, Y Iwatani, T Ueno: Dissecting naturally arising amino acid substitutions at position L452 of SARS-CoV-2 Spike. J Virol 96: e01162-22 (2022) doi:10.1128/jvi.01162-22

3. B Meng, A Abdullahi, I Ferreira, N Goonawardane, A Saito, I Kimura, D Yamasoba, P Gerber, S Fatihi, S Rathore, S Zepeda, G Papa, S Kemp, T Ikeda, M Toyoda, TS Tan, J Kuramochi, S Mitsunaga, T Ueno, K Shirakawa, A Takaori-Kondo, T Brevini, D Mallery, O Charles, The CITIID-NIHR BioResource COVID-Collaboration, The Genotype to Phenotype Japan (GP-Japan) Consortium members, Ecuador-COVID19 Consortium, J Bowen, A Joshi, A Walls, L Jackson, D Martin, K Smith, J Bradley, J Briggs, J Choi, E Madissoon, K Meyer, P Mlcochova, L Ceron-Gutierrez, R Doffinger, S Teichmann, A Fisher, M Pizzuto, A de Marco, D Corti, M Hosmillo, J Hyeon Lee, L James, L Thukral, D Veesler, A Sigal, F Sampaziotis, I Goodfellow, N Matheson, K Sato, R Gupta. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature 603, 706–714 (2022)

4. D Yamasoba, I Kimura, H Nasser, Y Morioka, N Nao, J Ito, K Uriu, M Tsuda, J Zahradnik, K Shirakawa, R Suzuki, M Kishimoto, Y Kosugi, K Kobiyama, T Hara, M Toyoda, Y Tanaka, E Butlertanaka, R Shimizu, H Ito, L Wang, Y Oda, Y Orba, M Sasaki, K Nagata, K Yoshimatsu, H Asakura, M Nagashima, K Sadamasu, K Yoshimura, J Kuramochi, M Seki, R Fujiki, A Kaneda, T Shimada, T Nakada, S Sakao, T Suzuki, T Ueno, A Takaori-Kondo, K Ishii, G Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, H Sawa, A Saito*, T Irie*, S Tanaka*, K Matsuno*, T Fukuhara*, T Ikeda*, K Sato: Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell, 185(12):2103-2115 (2022)

5. A Saito, T Tamura, J Zahradnik, S Deguchi, K Tabata, Y Anraku, I Kimura, J Ito, D Yamasoba, H Nasser, M Toyoda, K Nagata, K Uriu, Y Kosugi, S Fujita, M Shofa, M Begum, R Shimizu, Y Oda, R Suzuki, H Ito, N Nao, L Wang, M Tsuda, K Yoshimatsu, J Kuramochi, S Kita, K S-Tabata, H Fukuhara, K Maenaka, Y Yamamoto, T Nagamoto, H Asakura, M Nagashima, K Sadamasu, K Yoshimura, T Ueno, G Schreiber, A T-Kondo, The Genotype to Phenotype Japan (G2P-Japan) Consortium, K Shirakawa, H Sawa, T Irie, T Hashiguchi, K Takayama, K Matsuno, S Tanaka, T Ikeda, T Fukuhara, K Sato: Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe. 30:1540-1555 (2022)

6. S Ishido, H Ogura, J Gohda, M Yamamoto, Y Takesue, A Son, S Doi, K Matsushita, F Isobe, Y Fukuda, TP Huang, T Ueno, H Murakami, Y Kawaguchi, J Inoue, K Shirai, J Hirata, S Yamasaki, X Lu, N Mambo: Dysfunctional Sars-CoV-2 M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. Nat Commun. 13(1):7063 (2022)

7. I Kimura, D Yamasoba, H Nasser, J Zahradnik, Y Kosugi, J Wu, K Nagata, K Uriu, Y Tanaka, J Ito, R Shimizu, TS Tan, E Butlertanaka, H Asakura, K Sadamasu, K Yoshimura, T Ueno, A T-Kondo, G Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, M Toyoda, K Shirakawa, T Irie, A Saito, S Nakagawa, T Ikeda, K Sato. The SARS-CoV-2 Omicron spike S375F mutation decreases spike cleavage efficacy, fusogenicity and ACE2 binding affinity. iScience. 2022; 25(12):105720